ARCHIVES

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

This article is from The Cancer Letter archive.

Vol. 14 No. 35 | August 26, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

Mack, Specter Hit White House Budget Proposal For NIH.

February 18, 2000

CCOP Summary Statements Soon To Be Available

April 22, 1983

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

UCSF. Roswell Park Win National Cooperative Drug Discovery Group Awards; RFA To Be Reissued

June 15, 1984